Promotor – Prof Livio Pagano, Fondazione Policlinico Universitario A. Gemelli –IRCCS -Università Cattolica del Sacro Cuore, Roma, Italia
Steering Committee – Prof Nikolai Klimko, University of Saint Petersburg, RussiaProf Anthony Pagliuca, King’s College Hospital LondonProf Martin Hoenigl, University of Graz, AustriaProf Paolo Corradini, University of Milano, ItaliaDr Alessandro Busca, Ospedale San Giovanni Battista, Torino, ItaliaProf Francesco Passamonti, University of Insubria, Varese, ItaliaDr Philipp Köhler, University Hospital Cologne, GermanyProf Oliver Cornely, University Hospital Cologne, Germany.
To the best of our knowledge, no data are available at present on SARS-CoV-2 infection in patients with HM. However, the COVID-19 pandemic has presented unique challenges and learning opportunities on hematological malignancies. The future trajectory of this pandemic seems to be still uncertain, and hematological communities must continue to prepare for its widespread impact.In this project, we will implement a cooperation between all hematology department members ofEHA in order to assess epidemiological data on incidence and outcome of HM patients infected by SARS-CoV-2. We will provide useful information to inform individualized plan for HM patients.